Quantum-si to develop acceleration platform and advance core technologies in collaboration with nvidia

Branford, conn.--(business wire)--quantum-si incorporated (nasdaq: qsi) (“quantum-si,” “qsi” or the “company”), the protein sequencing company™, today announced a collaboration with nvidia to develop its new proteomics platform, proteus™, and advance quantum-si's core technologies of amino acid binders and aminopeptidases using nvidia ai and accelerated computing. this collaboration aims to significantly enhance data processing speeds to handle the increased data volume from proteus. by leverag.
QMCO Ratings Summary
QMCO Quant Ranking